Citigroup’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-54,000
Closed -$2.07M – 5704
2024
Q1
$2.07M Buy
+54,000
New +$2.62M ﹤0.01% 2410
2013
Q3
– Sell
-40,000
Closed -$1.03M – 6903
2013
Q2
$1.03M Buy
+40,000
New +$1.05M ﹤0.01% 2877

Other funds holding MED

Citigroup's MED Position: Q3 2026 in Review

Citigroup opened a new position in Medifast (MED) in Q3 2026: 546 shares worth $6.29K. The stake represents ﹤0.01% of the portfolio and ranks #5311 among its holdings. This is a return to the name: Citigroup previously reported a position in MED as recently as Q1 2026.

Citigroup first reported a position in MED in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.13M in Q2 2021. 41 funds tracked by Wall St. Rank hold MED as of Q3 2026.

  • Citigroup held 546 shares of Medifast worth $6.29K as of Q3 2026.
  • Medifast was a new Citigroup position in Q3 2026.
  • Medifast made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5311 holding.
  • Citigroup first reported a position in Medifast in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Medifast position peaked at $3.13M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.